vimarsana.com

Page 228 - சந்தைப்படுத்தல் தகவல்தொடர்புகள் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

MoSys Expands Patent Portfolio with Purchase of Custom Algorithm Search Patents

MoSys Expands Patent Portfolio with Purchase of Custom Algorithm Search Patents
pittsburghstar.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pittsburghstar.com Daily Mail and Mail on Sunday newspapers.

SkinPen® Precision Now Under Direct Management in the United Kingdom and Ireland

SkinPen® Precision Now Under Direct Management in the United Kingdom and Ireland
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

U S and EU Kidney Groups Align for Global Innovation Consortium

U.S. and EU Kidney Groups Align for Global Innovation Consortium WASHINGTON, April 10, 2021 /PRNewswire/ The American Association of Kidney Patients (AAKP), the largest U.S. kidney patient organization, today joined the European Kidney Patients Federation (EKPF) and the European Kidney Health Alliance (EKHA) in a new collaboration designed to expand the role of kidney patient consumers as central influencers in policy deliberations related to kidney research investments, more inclusive clinical trials, accelerated innovations, and improved health outcomes. The collaborative effort will boost The Decade of the Kidney an AAKP global initiative, launched in 2019 for the 2020-2030 decade, to support a patient-led international consortium to drive kidney disease as a global health priority and to better align governmental regulatory and payment policies so that barriers blocking rapid entry of treatment innovations into consumer markets are removed. Internationally, kidney patients

ITM Presents Design for Ongoing Phase III COMPETE Trial with n c a 177Lu-Edotreotide at AACR Annual Meeting 2021

(0) First pivotal study to compare Peptide Receptor Radionuclide Therapy (PRRT) in patients with Grade 1 and 2 gastroenteropancreatic neuroendocrine tumors (GEP-NETs) with approved standard of care ITM AG today announced the presentation of a trial-in-progress poster highlighting its ongoing Phase III trial COMPETE with n.c.a. 177Lu-Edotreotide in patients with gastroenteropancreatic neuroendocrine tumors (GEP-NETs) at the virtual American Association for Cancer Research (AACR) Annual Meeting 2021. The poster will be presented in video format as part of the Phase III trials in progress poster session by Mona M. Wahba, MD, Deputy Chief Medical Officer at ITM. It will be available following the e-poster website launch on April 10, 2021, at 8:30 am ET 2:30 pm CET and remain available for viewing through June 21, 2021.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.